NYMU Taipei/Part List
From 2007.igem.org
(Difference between revisions)
| Line 20: | Line 20: | ||
|12 | |12 | ||
|pSB1A2 | |pSB1A2 | ||
| + | |- | ||
| + | |AU43-C7 | ||
| + | |INS | ||
| + | | | ||
| + | |human insulin | ||
| + | | | ||
| + | |C | ||
|- | |- | ||
|N/A | |N/A | ||
| Line 26: | Line 33: | ||
|alpha chain of human insulin | |alpha chain of human insulin | ||
|63 | |63 | ||
| - | | | + | | |
|- | |- | ||
|N/A | |N/A | ||
| Line 33: | Line 40: | ||
|beta chain of human insulin | |beta chain of human insulin | ||
|90 | |90 | ||
| - | | | + | | |
|- | |- | ||
|[http://partsregistry.org/Part:BBa_B0014 BBa_B0014] | |[http://partsregistry.org/Part:BBa_B0014 BBa_B0014] | ||
Revision as of 08:03, 16 August 2007
| Series | alias | Circuit | Description | length | plasmid (antibotics) |
|---|---|---|---|---|---|
| [http://partsregistry.org/Part:BBa_R0082 BBa_R0082] | pOmpC | 1 | Positively regulated, OmpR-controlled promoter | 108 | pSB1A2 |
| [http://partsregistry.org/Part:BBa_B0034 BBa_B0034] | RBS | 1,2,3 | The Elowitz RBS (Ribosome binding site) is the definition of efficiency 1.0 | 12 | pSB1A2 |
| AU43-C7 | INS | human insulin | C | ||
| N/A | INS_A | 1 | alpha chain of human insulin | 63 | |
| N/A | INS_B | 1 | beta chain of human insulin | 90 | |
| [http://partsregistry.org/Part:BBa_B0014 BBa_B0014] | D-term | 1,2,3 | Double translation terminator | 95 | pSB1AK3 |
| [http://partsregistry.org/Part:BBa_I14032 BBa_I14032] | pLacIQ | 2 | Constitutive Promoter, High Transcription | 37 | pSB2K3 |
| OmpRBS | 2 | OmpR binding sites | |||
| AV88-C6 | IDE | 2 | insulin degradation enzyme | A | |
| IGFBP3 | 2 | Insulin-like growth factor binding protein 3 | C | ||
| IGFBP7 | 2 | Insulin-like growth factor binding protein 7 | C |
- antibiotics keys
- A: [http://en.wikipedia.org/wiki/Ampicillin Ampicillin]
- K: [http://en.wikipedia.org/wiki/Kanamycin Kanamycin]
- C: [http://en.wikipedia.org/wiki/Chloramphenicol Chloramphenicol]
